ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Next, we investigated the efficacy of CRISPR/Cas9 genome editing in clinical CML cells by SC, ABL sgRNA_1 and ABL sgRNA_2 virus infection with the optimized virus concentration.